I think Alan's point is this (at least, MY point is
I think Alan's point is this (at least, MY point is this):
We don't know if the number of shares outstanding is correct -- there are plenty of mistakes by data suppliers. All we know for sure is what the company tells us in the quarterly and annual reports.
If indeed the data reported by the various brokers etc are correct, as Alan says we do not know if an increase in shares is indeed selling to Aspire, OR if it is being issued to other entities for things like salaries or other work done for hire.
IF the stock in fact is sold to Aspire, we do NOT know if they are selling it or holding it.
So to conclude that:
a figure reported as the outstanding share count is correct,
and to then conclude that any increase in share count is stock sold to Aspire,
and then to conclude that Aspire turned around and sold it all into the market -
is ONLY speculation that is based on assumptions that are unproven and, at this time, unprovable.
It is NOT a fact that Aspire is buying shares, and then selling them, and that we can figure out the average daily shares sold. We don't even know if Aspire has bought shares, much less all the other assumptions based on that claim.
Grotty is absolutely correct, much of what is posted here is speculation. None of us has inside information.
And no one can state with certainty that any entity is buying or selling shares.
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Top 5 Most Recently Viewed Articles
ketteQ Secures Significant Funding for Global Advancement Funding round supports ketteQ's mission to deliver adaptive planning, AI-powered insights, and measurable results in months, not years. ketteQ, a leader in adaptive supply chain planning solutions, has successfully raised $20 million in Series B funding, spearheaded by Vocap Partners. This fresh funding is set to...
Continue Reading
Overview of ARK's Recent Trading Activity Cathie Wood's ARK ETFs are well-known for their assertive trading strategies, and the most recent report reveals their latest stock moves. The firm has made headlines again by announcing a series of buy and sell transactions that display its ongoing commitment to innovation and growth in the tech sector. Let's dive into the...
Continue Reading
NEWTON GOLF Announces Share Repurchase Authorization CAMARILLO, CA -- NEWTON GOLF Company (Nasdaq: SPGC), a leading innovator in the golf industry, has announced an authorization for a share repurchase program amounting to $1 million. This decision reflects a robust strategy to leverage market conditions and enhance shareholder value. The repurchase program will commence...
Continue Reading
Veritone's Legal Turbulence: Class Action Looms Alright, folks, here we go—a class action's got Veritone, Inc. (NASDAQ: VERI) in hot water, and it's not looking pretty. Legal eagles over at Robbins LLP are spearheading this suit, claiming the AI company botched its financial reporting. If you're holding VERI shares from October 14, 2025, through April 14, 2026, listen...
Continue Reading
TimelyCare Receives Prestigious Award for Mental Health Advocacy TimelyCare, known as higher education's most trusted virtual health and well-being provider, is honored to be recognized in the "Best in Business" list by Inc. for its exceptional advocacy in mental health. A Commitment to Student Health and Wellness As a winner in the Mental Health Advocacy category,...
Continue Reading